Diuretics

inhibit Na/Cl cotransport on distal convoluted tubule

thiazide (low ceiling)

Chlorothiazide (Diuril)

thiazide

Hydrochlorothiazide (Esidrix)

thiazide

Bendroflumethiazide (Naturetin)

thiazide

Indapamide (Lozol)

thiazide

Chlorthalidone (Hygroton, Thalinone)

thiazide

Metolazone (Mykrox, Zaroxolyn)

thiazide

Block carbonic anhydrase (CA) in the proximal convoluted tubule and prevent reabsorption of bicarbonate

Carbonic anhydrase inhibitors

Weak diuretics used clinically to correct acid-base disturbances (alkalosis)

Carbonic anhydrase inhibitors

used locally to tx glaucoma

Dorzolamide (Truopt)

May cause [at the exception of dorzalamide]: metabolic acidosis; increased serum levels of weak bases; hypokalemia; hyperuricemia; hyperammonemia

Carbonic anhydrase inhibitors

Acetazolamide (Diamox, sequel)

Carbonic anhydrase inhibitors

Dichlorphenamide (Daranide)

Carbonic anhydrase inhibitors

Methazolamide (Neptazane)

Carbonic anhydrase inhibitors

Dorzolamide (Trusopt)

Carbonic anhydrase inhibitors

Weak diuretic, used clinically to reduce blood glucose levels in type 2 diabetes

Sodium/glucose cotransporter inhibitors

Canagliflozin (Invokana)

Sodium/glucose cotransporter inhibitors

Dapagliflozin (Farxiga)

Sodium/glucose cotransporter inhibitors

Ampagliflozin (Jardiance)

Sodium/glucose cotransporter inhibitors

Block glucose and sodium cotransport (SGLT2) on proximal convoluted tubule

Sodium/glucose cotransporter inhibitors

May cause hypoglycemia and increase the risk of urinary track infections

Sodium/glucose cotransporter inhibitors

Very efficient diuretics used for the Prophylaxis of renal failure

Osmotic agents

Used to reduce intracranial pressure in cerebral edema

Osmotic agents

Easily filtered by glomerulus but not reabsorbed results in large water loss.

Osmotic agents

contraindicated in established renal failure

Osmotic agents

Will transiently increase extracellular volume leading to worsening, then will get better.

Osmotic agents

In the presence of kidney failure can cause serious edema and heart failure

Osmotic agents

Mannitol (Osmitrol)

Osmotic agents

Glycerol (Osmoglyn)

Osmotic agents

treatment of choice for edema due to cirrhosis or heart failure.

Loop diuretics (high ceiling)

Treatment of choice for all type of edematous states in patient with creatine clearance below 30 mL/min.

Loop diuretics (high ceiling)

Used for pulmonary edema.

Loop diuretics (high ceiling)

Used for acute hypercalcemia

Loop diuretics (high ceiling)

Act by inhibiting the Na+/K+/2Cl- cotransporter (NKCC2) in the thick ascending limb of the loop of Henle

Loop diuretics (high ceiling)

May cause hypokalaemia (potassium wasting)

Loop diuretics (high ceiling)

may increase blood glucose.

Loop diuretics (high ceiling)

May cause; hypokalaemia (potassium wasting) and metabolic alkalosis; hypomagnesaemia; hyperuricemia; may also increase blood glucose.

Loop diuretics (high ceiling)

Bumetanide (Bumex)

Loop diuretics (high ceiling)

Ethacrynic acid (Edecrin)

Loop diuretics (high ceiling)

Furosemide (Lasix)

Loop diuretics (high ceiling)

Torsemide (Demadex)

Loop diuretics (high ceiling)

Used in primary hyperaldosteronism

Aldosterone antagonists (potassium sparing)

To counteract potassium loss caused by more powerful diuretics

Aldosterone antagonists (potassium sparing)

reduces the expression of sodium channel and Na+K+ATPase in distal end of distal convoluted tubules, which results in decreased Na+ reabsorption and K+ excretion in the urine.

Aldosterone antagonism

Antiendrogenic effect can lead to impotence and gynecomastia [less with Eplerenone]

Aldosterone antagonists (potassium sparing)

Spironolactone (Aldactone)

Aldosterone antagonists (potassium sparing)

Eplerenone (Inspra)

Aldosterone antagonists (potassium sparing)

Triamterene (Dyrenium)

Used to counteract potassium loss caused by more powerful diuretics

Amiloride (Midamor)

Used to counteract potassium loss caused by more powerful diuretics

May cause hyperkalemia

Other potassium sparing agents

Disrupt sodium-potassium exchange in the distal nephron indirectly by inhibiting epithelial sodium channels (ENaC)

Other potassium sparing agents

Used in syndrome of inappropriate ADH secretion including heart failure

Vasopressin antagonists

induces translocation of aquaporin (AQP2) to the membrane of collecting ducts

Vasopression (ADH)

V1a and V2 receptor antagonist

Conivaptan (Vaprisol)

V2 receptor antagonist

Tolvaptan

Infusion site reactions are common

Vasopressin antagonists

Conivaptan (Vaprisol)

Vasopressin antagonists

Tolvaptan (Samaca)

Vasopressin antagonists

K+ and Na+ strongly excreted

loop diuretics

K+ and Na+ moderately excreted

thiazides

Na+ strongly excreted, K+ weakly excreted

Osmotic diuretics

used to treat congestive heart failure

loop diuretics

used to treat cirrhosis

loop diuretics

used to treat pulmonary edema

loop diuretics

used to treat nephrotic syndrome

loop diuretics

used to tx renal impariment

loop diuretics

used to treat glaucoma

carbonic anhydrase inhibitors

used to tx high-altitude sickness

carbonic anhydrase inhibitors

used to tx nephrolithiasis

thiazides

used to tx htn

thiazides

used to tx diabetic insipidus

thiazides

used to tx hyercalcemia

loop diuretics

used to tx hyperaldosteronism

K+ sparing diuretics

used to tx hypokalemia

K+ sparing duretics